VIDA Diagnostics, Inc. ("VIDA"), a leader in AI-powered lung imaging analysis tools, has announced the hiring of Todd Johnson as its new Chief Technology Officer. Johnson is an enterprise imaging, as well as advanced clinical applications industry veteran and in the role, he will ensure the company's AI (artificial intelligence) insights are accessible to a larger audience of clinicians in order to improve the diagnosis and treatment of lung disease. He will report directly to company CEO Susan Wood, Ph.D.
"Technology supporting early and accurate diagnosis and management of lung and respiratory disease has become of increasing importance amidst the global COVID-19 pandemic, especially as evidence builds for long-term lung damage," said Wood. "Todd's depth of expertise further strengthens our leadership team and positions us well for accelerated market expansion in the pulmonary clinical setting."
Johnson brings over 25 years' experience in the clinical imaging and healthcare IT industries to the executive team at VIDA. During his career, he has managed accelerating medical technologies, including advanced clinical applications, enterprise imaging, and data solutions, all working toward the goal of creating better patient outcomes. Johnson most recently served as the Chief Technology Officer of Evident Inc., where he helped transform data communication practices in the dental industry. Before that, he held senior roles at Change Healthcare (formerly McKesson Imaging) and Toshiba's medical imagning unit, Vital Images where he worked for 17 years.
"VIDA has married a deep clinical background with advanced AI technology and lab services to modernize the treatment of lung disease both in drug discovery and in the clinical setting," said Johnson. "I'm thrilled to be joining this exceptional company at a time when it is more important than ever to focus on and improve care for patients with or at-risk of lung disease."